{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:04:45Z","timestamp":1760123085526,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.semnephrol.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T18:27:43Z","timestamp":1619116063000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opioids in Hemodialysis Patients"],"prefix":"10.1016","volume":"41","author":[{"given":"Sahir","family":"Kalim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar U.","family":"Nigwekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2021.02.003_bib0001","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpain.2018.07.006","article-title":"Prevalence and profile of high-impact chronic pain in the United States","volume":"20","author":"Pitcher","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0003","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2005020157","article-title":"Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients","volume":"16","author":"Weisbord","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0004","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.ajkd.2003.08.025","article-title":"Pain in hemodialysis patients: prevalence, cause, severity, and management","volume":"42","author":"Davison","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/sdi.12196","article-title":"Pain in chronic kidney disease: a scoping review","volume":"27","author":"Davison","year":"2014","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0006","first-page":"1131","article-title":"Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review","volume":"10","author":"Brkovic","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0007","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1046\/j.1523-1755.63.s84.23.x","article-title":"Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients","volume":"63","author":"Kronenberg","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2019.07.013","article-title":"Symptoms of secondary hyperparathyroidism in patients receiving maintenance hemodialysis: a prospective cohort study","volume":"75","author":"Levy","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0009","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ckj\/sfu034","article-title":"Falls among hemodialysis patients: potential opportunities for prevention?","volume":"7","author":"Kutner","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpainsymman.2009.08.008","article-title":"Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients","volume":"39","author":"Davison","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0012","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2215\/CJN.05180418","article-title":"Clinical pharmacology considerations in pain management in patients with advanced kidney failure","volume":"14","author":"Davison","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpainsymman.2005.05.013","article-title":"The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients","volume":"30","author":"Davison","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0014","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40265-018-0980-9","article-title":"Assessing and treating chronic pain in patients with end-stage renal disease","volume":"78","author":"Coluzzi","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0015","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2215\/CJN.00220114","article-title":"Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis","volume":"9","author":"Weisbord","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction","volume":"146","author":"Martell","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0017","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1681\/ASN.2017010098","article-title":"Opioid prescription, morbidity, and mortality in United States dialysis patients","volume":"28","author":"Kimmel","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0018","first-page":"110","article-title":"Association between quality of life and anxiety, depression, physical activity and physical performance in maintenance hemodialysis patients","volume":"2","author":"Li","year":"2016","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0019","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/j.pain.0000000000000763","article-title":"New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation","volume":"158","author":"Salas","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0020","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMc1905100","article-title":"Initial opioid prescriptions among U.S. patients, 2012-2017","volume":"380","author":"Alexander","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0021","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJMsa1807069","article-title":"Initial opioid prescriptions among U.S. commercially insured patients, 2012-2017","volume":"380","author":"Zhu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0022","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1681\/ASN.2017010098","article-title":"Opioid prescription, morbidity, and mortality in United States dialysis patients","volume":"28","author":"Kimmel","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0023","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.04770610","article-title":"Opioid and benzodiazepine use in end-stage renal disease: a systematic review","volume":"6","author":"Wyne","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.ajkd.2013.09.008","article-title":"Opioid use in the US hemodialysis population","volume":"63","author":"Butler","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjmed.2015.10.002","article-title":"Trends in opioid prescriptions among part D Medicare recipients from 2007 to 2012","volume":"129","author":"Kuo","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0026","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1053\/j.ajkd.2015.07.029","article-title":"Opioid use in hemodialysis patients","volume":"66","author":"Olivo","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000495353","article-title":"Trends in opioid prescribing among hemodialysis patients, 2007-2014","volume":"49","author":"Daubresse","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0028","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jamainternmed.2018.6101","article-title":"Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV","volume":"179","author":"Edelman","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0031","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neubiorev.2013.08.006","article-title":"The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways","volume":"37","author":"Garland","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0032","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1681\/ASN.2017091041","article-title":"Prescription opioids for pain management in patients on dialysis","volume":"28","author":"Han","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0033","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/pme.12183","article-title":"The economic burden of opioid-related poisoning in the United States","volume":"14","author":"Inocencio","year":"2013","journal-title":"Pain Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0034","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0035","article-title":"Dialysis, opioids, and pain management: where's the evidence?","volume":"14","author":"Atkinson","year":"2014","journal-title":"Letters to the Editor"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0036","first-page":"5","article-title":"The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice","volume":"21","author":"Murtagh","year":"2007","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0037","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1103313","article-title":"Long interdialytic interval and mortality among patients receiving hemodialysis","volume":"365","author":"Foley","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0038","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2215\/CJN.09910917","article-title":"Opioid analgesics and adverse outcomes among hemodialysis patients","volume":"13","author":"Ishida","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0039","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1681\/ASN.2019090904","article-title":"Hip fracture risk among hemodialysis-dependent patients prescribed opioids and gabapentinoids","volume":"31","author":"Vangala","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0040","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0041","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2215\/CJN.13341019","article-title":"Benzodiazepines, codispensed opioids, and mortality among patients initiating long-term in-center hemodialysis","volume":"15","author":"Muzaale","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3865924","article-title":"Opioid safety and concomitant benzodiazepine use in end-stage renal disease patients","volume":"2019","author":"Ruchi","year":"2019","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0043","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000507725","article-title":"Concomitant use of gabapentinoids with opioids is associated with increased mortality and morbidity among dialysis patients","volume":"51","author":"Waddy","year":"2020","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0044","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0045","unstructured":"History of the opioid epidemic [cited 2020 December 29]. Available from: https:\/\/dualdiagnosis.org\/infographics\/history-of-the-opioid-epidemic."},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0046","unstructured":"Beshak L. Civilization's painkiller: a brief history of opioids [cited 2020 December 29]. Available from:https:\/\/www.newsweek.com\/civilization-painkiller-brief-history-opioid-486164."},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0047","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000170017","article-title":"Elevated plasma levels of opioid peptides and delta sleep-inducing peptide but not of corticotropin-releasing hormone in patients receiving chronic hemodialysis","volume":"9","author":"Hegbrant","year":"1991","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0048","first-page":"190","article-title":"The role of endogenous opioids in the baroreflex dysfunction of dialysis patients","volume":"21","author":"Zoccali","year":"1985","journal-title":"Proc Eur Dial Transplant Assoc Eur Ren Assoc"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0049","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/papr.12483","article-title":"Dialyzability of oxycodone and its metabolites in chronic noncancer pain patients with end-stage renal disease","volume":"17","author":"Samolsky Dekel","year":"2017","journal-title":"Pain Pract"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0050","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.pain.2013.08.015","article-title":"Intradialytic clearance of opioids: methadone versus hydromorphone","volume":"154","author":"Perlman","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0051","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejpain.2005.12.001","article-title":"Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine","volume":"10","author":"Filitz","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0052","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0053","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0054","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/clinchem\/33.7.1251","article-title":"Opiates in poppy seed: effect on urinalysis results after consumption of poppy seed cake-filling","volume":"33","author":"Pettitt","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0055","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.286.24.3115","article-title":"Quinolones and false-positive urine screening for opiates by immunoassay technology","volume":"286","author":"Baden","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0056","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4155\/bio.09.81","article-title":"False-positive' and 'false-negative' test results in clinical urine drug testing","volume":"1","author":"Reisfield","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0057","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s13181-012-0274-7","article-title":"Laboratory testing for prescription opioids","volume":"8","author":"Milone","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0058","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jpain.2019.04.007","article-title":"Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: a systematic review","volume":"20","author":"Wilson","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0059","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/JCN.0000000000000089","article-title":"Adherence to a low-sodium diet in patients with heart failure is best when family members also follow the diet: a multicenter observational study","volume":"30","author":"Chung","year":"2015","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.04.014","article-title":"Physical and mental quality of life in patients with end-stage liver disease and their informal caregivers","volume":"19","author":"Hansen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0061","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijnurstu.2014.11.005","article-title":"Patterns and predictors of patient and caregiver engagement in heart failure care: a multi-level dyadic study","volume":"52","author":"Lee","year":"2015","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0062","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1074840717745669","article-title":"The theory of dyadic illness management","volume":"24","author":"Lyons","year":"2018","journal-title":"J Fam Nurs"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0063","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1037\/amp0000066","article-title":"Close relationships and the management of chronic illness: associations and interventions","volume":"72","author":"Martire","year":"2017","journal-title":"Am Psychol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0064","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1037\/0090-5550.52.2.121","article-title":"Couple-oriented education and support intervention: effects on individuals with osteoarthritis and their spouses","volume":"52","author":"Martire","year":"2007","journal-title":"Rehabil Psychol"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11764-015-0509-0","article-title":"Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the Exercising Together project","volume":"10","author":"Winters-Stone","year":"2016","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.semnephrol.2021.02.003_bib0066","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/cncr.31906","article-title":"Self-management intervention for head and neck cancer couples: results of a randomized pilot trial","volume":"125","author":"Badr","year":"2019","journal-title":"Cancer"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929521000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929521000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:37:35Z","timestamp":1759448255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929521000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0270929521000176"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2021.02.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"type":"print","value":"0270-9295"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids in Hemodialysis Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}